Lv62
2030 积分 2023-07-02 加入
Identifying cardiovascular toxicity associated with sphingosine 1-phosphate receptor modulators: A case-control study based on the FDA adverse event reporting system
30天前
已完结
Immune-related adverse events of immune checkpoint inhibitors combined with angiogenesis inhibitors: A real-world pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database (2014–2022)
2个月前
已完结
Identifying cardiovascular toxicity associated with sphingosine 1-phosphate receptor modulators: A case-control study based on the FDA adverse event reporting system
2个月前
已完结
Differences in the Adverse Event Burden of Corticosteroid Use in Inflammatory Bowel Disease as Reported Between Adverse Event Reporting Systems and a Patient Questionnaire
4个月前
已完结
Bronchoalveolar Lavage Fluid Cellular Analysis and Radiologic Patterns in Patients with Fibrotic Interstitial Lung Disease
4个月前
已完结
Development and Validation of a Clinical, CT, Genomic Classifier and BAL Scoring System for Diagnosing IPF
4个月前
已完结
Pharmacovigilance insights into medication-induced risk of dural arteriovenous fistula
5个月前
已完结
Reported Psychiatric Adverse Events Among Isotretinoin Users: Monitoring Priorities from a 20-Year FAERS Database Study
5个月前
已完结
Post-marketing safety evaluation of Vortioxetine: A decade-long pharmacovigilance study based on the FAERS database
5个月前
已完结
Detection of risk signals for ustekinumab in the real world using the FDA adverse event reporting system (FAERS)
5个月前
已完结
皖公网安备34019202002308
